Purpose: To assess the effect of dry eye disease (DED) in graft donors on dendritic cell (DC) maturation, host T-cell sensitization, and corneal allograft rejection.
C
orneal transplantation is one of the most common tissue grafting procedures worldwide, with over 65,000 cases performed annually. 1 It is widely recognized that the condition of the recipients' host bed can affect graft survival: corneal grafts performed in avascular "low-risk" host beds enjoy a high survival rate as a result of corneal immune privilege 2 ; in contrast, over 50% of grafts are rejected in "high-risk" hosts whose graft beds are characterized by neovascularization and inflammation. 3 However, very little is known about how the state of the donor ocular surface can affect the outcome of corneal transplantation. Donor factors that are currently assessed as possibly affecting the graft outcome include endothelial cell density, history of infection, disseminated cancer, ocular surgery, and possibly age. However, a history of ocular surface disease or previous corneal inflammation is not assessed in the eye bank screening process.
Inflammation and cell death are considered as major contributors to dry eye disease (DED)-associated loss of corneal integrity and barrier function. 4, 5 DED is one of the most common ocular disorders affecting tens of millions of people worldwide 6, 7 and is associated with disturbance of ocular surface immunohomeostasis. 8 Aging, hormonal changes, environmental factors, and prolonged work with visual display terminals 9 have contributed to the growing DED population. The high prevalence of DED is at least of theoretical concern in the context of transplantation, because it has been established that DED promotes maturation of antigen-presenting cells (APCs), 10 T-cell activation, and lymphangiogenesis, 11, 12 all of which can amplify immune reactivity and possibly pose a significant risk to corneal grafts if the tissue is transplanted.
We investigated the effects of DED in donor grafts on APC maturation, proinflammatory cytokine production, and graft survival using a validated murine model of corneal transplantation.
MATERIALS AND METHODS

Mice and Anesthesia
Six-to 8-week-old C57BL/6 (H-2b) and BALB/c (H-2d) female mice were purchased from Charles River Laboratories (Wilmington, MA). Mice were housed in a specific pathogenfree environment at the Schepens Eye Research Institute animal facility. All animals were treated according to the guidelines established by the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and Public Health Review, and all procedures were approved by the Institutional Animal Care and Use Committee. Anesthesia was administered intraperitoneally (ketamine/xylazine solution at a dose of 120 mg/kg body weight and 20 mg/kg body weight, respectively).
Induction of DED in Donor Corneal Tissue
Acute DED was induced by exposing C57BL/6 mice to the controlled-environment chamber with a relative humidity of ,20%, airflow of 15 L/min, and a constant temperature of 21 to 23°C for 14 consecutive days, as previously described. 13 
Orthotropic Corneal Transplantation and Assessment of Graft Survival
The procedure for corneal orthotopic transplantation, in which corneal grafts from C57BL/6 mice are transplanted to BALB/c recipient mice, has been well established and described previously. 14 Briefly, the central cornea was marked with a 2-mm-diameter trephine and excised from a donor C57BL/6 mouse using Vannas scissors (Storz Instruments, San Dimas, CA). The graft bed was prepared by excising a 1.5-mm central corneal button from a BALB/c mouse. The donor button was then placed onto the recipient bed and secured with 8 interrupted 11-0 nylon sutures. Corneal sutures were removed 7 days after surgery. Graft survival was evaluated once a week using a slit-lamp biomicroscope for 8 weeks. A standardized opacity grading (range, 0-5+) system was used to define rejection, and corneas with an opacity score of 2+ for 2 consecutive examinations were considered rejected. 15 
In Vivo Confocal Microscopy
In vivo confocal microscopy (IVCM) [Heidelberg Retina Tomograph II Rostock Cornea Module (Heidelberg Engineering GmbH, Heidelberg, Germany)] was used to examine dendritic cells (DCs) in the cornea. Healthy or DED donor mice were anesthetized and placed on the microscope stand, and the eyes were coated with GenTeal Gel (Novartis, St. Louis, MO). Images were taken covering a corneal section of 400 · 400 mm 2 and transverse optical resolution of 1 mm/pixel. The number of DCs, morphologically identified as bright dendritiform cells, was analyzed quantitatively using ImageJ.
Flow Cytometry Analysis
Cervical draining lymph nodes (dLNs) were harvested, and single-cell suspensions were prepared. To avoid nonspecific staining, cells were blocked with an anti-FcR blocking antibody (eBioscience, San Diego, CA). Mature DCs were stained with anti-CD11c Alexa 488 (N418; BioLegend, San Diego, CA), anti-CD45 PE (30-F11; eBioscience), and anti-I-A/I-E PeCy7 (M5/114.15.2; BioLegend). Tregs were stained with anti-CD4 FITC (RM4-5), anti-CD25 PE (PC61), and antiFoxp3 PECy7 (FJK-16s) (BioLegend). For intracellular interferon (IFN)-g and IL-17 staining, cells were stimulated with 50 ng/mL phorbol 12-myristate 13-acetate (PMA) and 500 ng/mL ionomycin (Sigma-Aldrich, St. Louis, MO) for 12 hours at 37°C and 5% CO 2 in the presence of GolgiStop (0.7 mL per 100 mL cell culture media; BD Biosciences, San Jose, CA) to inhibit cytokine secretion. Cells were then stained with anti-CD4 FITC, anti-IFN-g APC (XMG1.2), and anti-IL-17 PECy7 (TC11-18H10.1) (BioLegend). All antibodies and their matched isotype controls and fixation and permeabilization buffers were purchased from eBioscience. Stained cells were examined using the LSRII Flow Cytometer (BD Biosciences, Franklin Lakes, NJ) and analyzed using FlowJo software X 10.0.7 (FlowJo LLC, Ashland, OR).
Magnetic Cell Sorting
CD4 + CD25 2 conventional T cells (Tconv) and CD4 + CD25 + regulatory T cells (Tregs) from BALB/c mice and APCs from C57BL/6 mice were isolated by magnetic cell sorting (MACS) using Treg and CD90.2 isolation kits, respectively, according to the manufacturer's instructions (Miltenyi Biotec, Bergisch-Gladbach, Germany).
Suppression Assay
Conventional T cells (Tconv; 1 · 10 5 ) isolated from the dLNs of naive BALB/c mice were cocultured with Tregs (5 · 10 4 ) from transplant recipients (at posttransplantation day 14), T-cell-depleted allogeneic splenocytes from C57BL/ 6 mice (1 · 10 5 ), and 1 mg/mL anti-CD3 antibody (145-2C11, BioLegend) for 3 days. Proliferation of CD3-stimulated Tconv cells without adding Tregs served as the control with 0% suppression. Proliferation was measured using the bromodeoxyuridine (BrdU) incorporation assay (EMD Millipore, Billerica, MA), and percent suppression was calculated using the following formula: % suppression = [(Tconv proliferation without Tregs 2 Tconv proliferation with Tregs)/(Tconv proliferation without Tregs)] · 100.
Enzyme-Linked Immunospot Assay
The enzyme-linked immunospot assay (ELISPOT) was performed to measure the number of spots of directly and indirectly primed T cells, as described previously. 16 Briefly, 96-well ELISPOT plates (Whatman Polyfiltronics, Newton, MA) were coated with 4 mg/mL primary anti-IFNg mAb (BD Pharmingen, San Diego, CA) in sterile PBS for 48 hours. Then, plates were washed and blocked for 1.5 hours with PBS containing 1% bovine serum albumin, and cells were added to these plates. Purified T cells (5 · 10 5 ) sorted by CD90.2 + MACS from the dLNs of the grafted BALB/c mice (5 in each group, 2 weeks after transplantation of C57BL/6 donor corneas) were pooled and then incubated in triplicates with C57BL/6 APCs (5 · 10 5 , CD90.2 2 , MACS sorted splenocytes) for 48 hours to quantify frequencies of directly allosensitized T cells. To quantify frequencies of indirectly allosensitized T cells, syngeneic BALB/c APCs (5 · 10 5 ) pulsed with the sonicated donor antigen (2 · 10 7 , C57BL/6 APCs/mL) were incubated with BALB/c recipient T cells harvested from dLNs of BALB/c recipients with a healthy C57BL/6 donor cornea serving as the control. After washing, biotinylated anti-IFN-g detection mAb was added at 2 mg/ mL (BD Pharmingen, San Diego, CA) and incubated for 2 hours at room temperature. Plates were then washed, incubated for 1.5 hours with avidin-HRP, and developed using the 3-amino-9-ethylcarbazole substrate for 30 minutes (MN 51-2577KC, BD Biosciences). The resulting spots were analyzed using the computer-assisted ELISPOT image analyzer (Cellular Technology Ltd, Cleveland, OH).
Statistical Analysis
The Student t test was used to compare the means between 2 groups. Two-way analysis of variance was used to compare graft opacity scores between the groups at different time points (Bonferroni post hoc test). Kaplan-Meier analysis was used to construct survival curves, and the log-rank test was used to compare corneal graft survival. Data are presented as mean 6 SEM and considered statistically significant at *P , 0.05, **P , 0.01, and ***P , 0.001.
RESULTS
Recipients of Grafts With DED Demonstrate Reduced Allograft Survival
Fully MHC-and minor H-allodisparate dry eye or control (healthy) donor corneas derived from C57BL/6 mice were grafted onto naive BALB/c recipients, and graft survival was assessed until posttransplantation week 8. We found that graft survival was significantly lower (Fig. 1A, 10% in the DED donor group vs. 50% in healthy control donors; log-rank test, n = 10, *P = 0.0215), and graft opacity scores were significantly higher (Fig. 1B , n = 10, ***P , 0.0001) in hosts who had received tissue from DED donors compared with healthy tissue recipients.
DED in the Donor Tissue Promotes DC Maturation in the Cornea and dLNs of the Host
Using IVCM, we first evaluated the density of DCs in the cornea of healthy and DED donor mice before transplantation. DCs were identified morphologically as bright dendritiform cells. 17 There was a markedly increased number of DCs in the examined corneal sections of mice with DED compared with healthy controls (Figs. 2A, B , DED cornea 7.6 6 0.7 cells vs. healthy cornea 2.5 6 0.5 cells, n = 10, ***P , 0.001). APCs in the ocular surface and lymphoid tissues, including dLNs, play a critical role in priming host CD4 effector T cells in corneal transplantation. 18 Thus, we next determined the frequencies of mature CD45 + CD11c + MHCII high DCs in the corneas and dLNs by flow cytometry 14 days after corneal transplantation (Figs. 2C-F) . The frequencies of mature DCs were significantly increased in both grafted cornea (Figs. 2C, D , n = 5, ***P , 0.001) and dLNs (Figs. 2E, F, n = 5, *P , 0.05) of recipients of DED grafts compared with those receiving healthy control donor tissue. The frequencies of immature (MHCII 2 ) DCs remained similar in both groups (data not shown).
DED in Donor Tissue Leads to Significantly Increased Th1 and Th17 Frequencies and Decreased Treg Function in the Recipient
IFN-g-producing CD4 + T cells are the principal mediators of acute allograft rejection. 19 We thus analyzed the frequencies of total IFN-g-producing CD4 + T cells in the dLNs 14 days after transplantation. We observed significantly higher frequencies of IFN-g + CD4 + T cells in dLNs of recipients of DED donor corneas compared with healthy tissue recipients (Figs. 3A, B , n = 5, **P = 0.0017). Because the proinflammatory cytokine IL-17 has also been implicated in the acute corneal allograft response 20 and DED, 8, 21 we analyzed the frequencies of IL-17-producing T cells in the dLNs 14 days after transplantation. Our results showed that recipients of DED donor corneas had significantly higher frequencies of Th17 cells in dLNs compared with healthy tissue recipients (Figs. 3C, D , n = 5, **P = 0.0061).
Tregs are crucial for allograft survival because they attenuate multiple facets of alloimmunity, 22 and Foxp3 is the FIGURE 1. Recipients of grafts with DED demonstrate reduced allograft survival. Corneal grafts were harvested from C57BL/6 mice with DED or from healthy C57BL/6 donors that served as the control. Corneal grafts were transplanted into healthy BALB/c host beds and observed weekly over 8 weeks. A, Kaplan-Meier survival curves showing graft survival of mice with healthy (control) versus DED grafts (n = 10/group, *P = 0.0215). B, Graft opacity scores were assessed using biomicroscopy (2-way analysis of variance with the Bonferroni post hoc test, n = 10/group, ***P , 0.0001).
Treg suppressive function in vitro, Tregs isolated from the dLNs of DED grafted recipients were cultured with naive T cells in the presence of donor APCs, and their capacity to suppress T-cell proliferation was measured. 23 Tregs from recipients grafted with DED donor tissue displayed a moderately reduced suppressive function compared with Tregs harvested from recipients of healthy (non-DED) corneal tissue (Fig. 3G , n = 6, ***P , 0.0001).
DED in Donor Cornea Activates Host T cells Through the Direct Pathway of Allosensitization
Given that host T cells are allosensitized either directly by donor APCs or indirectly by host APCs, 19 we investigated the frequencies of both directly and indirectly primed IFN-gproducing T cells using the ELISPOT assay at posttransplantation day 14 (Figs. 4A and 4B ). The frequencies of directly allosensitized T cells in hosts receiving DED donor tissue were significantly higher than recipients of healthy control tissue ( Fig. 4B ; n = 3, P = 0.015). No differences were observed in the levels of indirectly primed host T cells between the 2 groups ( Fig. 4B ; n = 3, P = 0.33).
DISCUSSION
Previous clinical and experimental studies have shown that transplant survival is significantly influenced by the host graft bed microenvironment. 3, 24 In this study, we show for the first time that grafting corneal tissue harvested from DED donors onto uninflamed healthy host beds significantly reduces graft survival, clearly indicating that DED donor status portends an increased risk for graft rejection, even when grafted onto healthy uninflamed recipient beds.
To determine the mechanisms that mediate the heightened alloimmunity observed in recipients of DED donor tissues, we evaluated several factors, including APC maturation, effector T-cell responses, and Treg suppressive function. Previous work by our group has shown that donor-derived APCs residing in graft tissue and graft-infiltrating host APCs can mediate direct and indirect pathways of allosensitization, respectively. 14, 24 These APCs can bear graft antigens and migrate to host lymphoid tissues, where they prime naive host T cells and promote alloreactivity. In general, mature MHC class II high DCs, the most potent APCs, promote T-cell immunity, whereas immature DCs (MHC class II 2 ) can contribute to T-cell tolerance. 25 Higher density of DCs has been shown in various inflammatory conditions such as DED. 17 Using IVCM, we similarly observed an increased number of DCs in donors with DED compared with healthy controls before transplantation. We found that the frequencies of mature CD11c + MHCII high DCs are significantly increased in the grafted corneas and the dLNs of recipients of grafts from DED donors. These data are in accord with those from a previous publication from our group, in which we reported increased corneal leukocytic (CD45 + CD11b + ) infiltration and activation in dry eye corneas. 10 Recent findings have shown that mature MHCII high DCs produce high levels of proinflammatory cytokines, such as IL-12, IL-1b, and IL-6, 25 through which they promote host T-cell responses. Based on our results, we hypothesize that the increased frequencies and activation (maturation) of passenger leukocytes present in DED corneas promote T-cell allosensitization and acute rejection in hosts bearing these grafted tissues. In accord with this hypothesis, we demonstrate that the direct pathway dominates in recipients of grafts from DED donors.
Recent studies, including those from our group, have suggested that DED is a T-cell-mediated autoimmune disorder. 26 Increased expression of Th1-associated IFN-g and Th17-associated IL-17, 21 and dysfunctional Tregs, has been associated with DED severity. In accord with these observations, our results show increased Th1 and Th17 responses, as well as reduced Treg function, in mice transplanted with DED corneas. Moreover, Th1-associated IFN-g-producing T cells are the principal mediators of acute corneal allograft rejection 19 whose function is kept in check by regulatory T cells that promote allotolerance by suppressing host T-cell sensitization and expansion. 27 Thus, balance between Th1 and Treg cells plays a critical role in determining graft survival. 23, 28 We observed significantly decreased Foxp3 expression, a transcription factor whose expression level highly correlates with the Treg function, 23 which suggests that increased effector Th1 cell activation and Treg dysfunction act in concert, leading to high rejection rates observed in recipients of grafts from donors with DED.
In summary, our findings demonstrate that corneal tissue derived from DED donors hampers graft survival by augmenting T-cell driven inflammation in the host. It is noteworthy that the amplified immune response to grafted tissue from DED donors documented in this study was seen in donors whose DED was not treated preoperatively or postoperatively with steroids or other immunomodulatory therapy. Because our previous work has shown a significant reduction in corneal immune cell infiltration in response to a variety of topical immune modulators, 10, 29, 30 we speculate that immunomodulatory treatments that suppress corneal inflammation, either before donor death/tissue procurement or after grafting, can dampen the effect of preexisting immune cell activation seen in DED donors on graft rejection. Based on the mouse-derived data in our experiments, we can speculate that, similarly, eye bank eyes from donors with moderate to severe DED may predispose grafted hosts to higher rejection rates. Because the presence of DED in the donor leads primarily to immune cell mobilization and activation in the donor stroma, we expect that the effect of DED on the graft outcome will be far more impactful in penetrating full-thickness grafting than in endothelial keratoplasty. These results warrant further exploration and confirmation in clinical studies, given the very high prevalence of DED in the population. If confirmed, it would mean that a significant minority of tissue donors might harbor a condition that portends a poor prognosis for hosts grafted with their corneas.
